| Selective inhibition of BET bromodomains P Filippakopoulos, J Qi, S Picaud, Y Shen, WB Smith, O Fedorov, ... Nature 468 (7327), 1067-1073, 2010 | 4220 | 2010 |
| Transcriptional activation triggers deposition and removal of the histone variant H3. 3 BE Schwartz, K Ahmad Genes & development 19 (7), 804-814, 2005 | 406 | 2005 |
| Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody H Haack, LA Johnson, CJ Fry, K Crosby, RD Polakiewicz, EB Stelow, ... The American journal of surgical pathology 33 (7), 984-991, 2009 | 389 | 2009 |
| Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes Z Ni, BE Schwartz, J Werner, JR Suarez, JT Lis Molecular cell 13 (1), 55-65, 2004 | 305 | 2004 |
| Differentiation of NUT midline carcinoma by epigenomic reprogramming BE Schwartz, MD Hofer, ME Lemieux, DE Bauer, MJ Cameron, NH West, ... Cancer research 71 (7), 2686-2696, 2011 | 209 | 2011 |
| Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains N Reynoird, BE Schwartz, M Delvecchio, K Sadoul, D Meyers, ... The EMBO journal 29 (17), 2943-2952, 2010 | 195 | 2010 |
| Transcriptional and developmental functions of the H3. 3 histone variant in Drosophila A Sakai, BE Schwartz, S Goldstein, K Ahmad Current Biology 19 (21), 1816-1820, 2009 | 191 | 2009 |
| CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry CY Lai, BE Schwartz, MY Hsu Cancer research 72 (19), 5111-5118, 2012 | 124 | 2012 |
| Cdk7 Is Required for Full Activation of Drosophila Heat Shock Genes and RNA Polymerase II Phosphorylation In Vivo BE Schwartz, S Larochelle, B Suter, JT Lis Molecular and cellular biology 23 (19), 6876-6886, 2003 | 83 | 2003 |
| Indirect immunofluorescent labeling of Drosophila polytene chromosomes: visualizing protein interactions with chromatin in vivo BE Schwartz, JK Werner, JT Lis Methods in enzymology 376, 393-404, 2003 | 35 | 2003 |
| Discovery and Targeting of the Signaling Controls of PNPLA3 to Effectively Reduce Transcription, Expression, and Function in Pre-Clinical NAFLD/NASH Settings BE Schwartz, V Rajagopal, C Smith, E Cohick, G Whissell, M Gamboa, ... Cells 9 (10), 2247, 2020 | 33 | 2020 |
| Chromatin assembly with H3 histones: Full throttle down multiple pathways BE Schwartz, K Ahmad Current topics in developmental biology 74, 31-55, 2006 | 13 | 2006 |
| N1-arylation of 1, 4-benzodiazepine-2-ones with diaryliodonium salts R Khan, R Felix, PD Kemmitt, SJ Coles, GJ Tizzard, J Spencer Synlett 29 (02), 193-198, 2018 | 5 | 2018 |
| Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension YY Tai, Q Yu, Y Tang, W Sun, NJ Kelly, S Okawa, J Zhao, ... Science Translational Medicine 16 (729), eadd2029, 2024 | 1 | 2024 |
| Methods of treating liver diseases DA Bumcrot, A Sehgal, AA Sigova, BE Schwartz, G Whissell, I Grossman, ... US Patent App. 17/268,431, 2022 | 1 | 2022 |
| Upregulation of a bile acid regulator by targeting regulatory RNAs can enhance hepatic bile acid efflux in PBC BE Schwartz, K Gnanapradeepan, M Rodriguez, R Kelkar, P Sathe, ... HEPATOLOGY 76, S1491-S1492, 2022 | | 2022 |
| Methods and compositions for treating urea cycle disorders A Sehgal, AA Sigova, I Zlobine, BE Schwartz, DA Bumcrot, V Rajagopal, ... US Patent App. 17/586,595, 2022 | | 2022 |
| Methods and compositions for treating urea cycle disorders A Sehgal, AA Sigova, I Zlobine, BE Schwartz, DA Bumcrot, V Rajagopal, ... US Patent 11,266,655, 2022 | | 2022 |
| Treating diseases via targeted modulation of gene signaling networks DA Bumcrot, A Sehgal, A Sigova, V Rajagopal, B Schwartz, C Smith US Patent App. 17/045,473, 2021 | | 2021 |
| Methods and compositions for treating urea cycle disorders, in particular otc deficiency A Sehgal, AA Sigova, I Zlobine, BE Schwartz, DA Bumcrot US Patent App. 16/753,530, 2020 | | 2020 |
